The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

There is an increasing interest in the intestinal microbiota as a critical regulator of the development and function of the immune, nervous, and endocrine systems. Experimental work in animal models has provided the foundation for clinical studies to investigate associations between microbiota compo...

Full description

Bibliographic Details
Main Authors: Hannah M. Kohl, Andrea R. Castillo, Javier Ochoa-Repáraz
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Diseases
Subjects:
probiotics
microbiota
microbiome
multiple sclerosis
EAE
Online Access:https://www.mdpi.com/2079-9721/8/3/33

Similar Items

Similar Items